全文获取类型
收费全文 | 1344844篇 |
免费 | 101428篇 |
国内免费 | 7155篇 |
专业分类
耳鼻咽喉 | 18990篇 |
儿科学 | 42999篇 |
妇产科学 | 38990篇 |
基础医学 | 195642篇 |
口腔科学 | 36685篇 |
临床医学 | 117644篇 |
内科学 | 260425篇 |
皮肤病学 | 27432篇 |
神经病学 | 102710篇 |
特种医学 | 52933篇 |
外国民族医学 | 419篇 |
外科学 | 204918篇 |
综合类 | 36982篇 |
现状与发展 | 22篇 |
一般理论 | 320篇 |
预防医学 | 96767篇 |
眼科学 | 31846篇 |
药学 | 105607篇 |
66篇 | |
中国医学 | 6567篇 |
肿瘤学 | 75463篇 |
出版年
2018年 | 14816篇 |
2017年 | 11396篇 |
2016年 | 12632篇 |
2015年 | 15360篇 |
2014年 | 20592篇 |
2013年 | 28398篇 |
2012年 | 39544篇 |
2011年 | 42408篇 |
2010年 | 25201篇 |
2009年 | 23034篇 |
2008年 | 39132篇 |
2007年 | 41960篇 |
2006年 | 42616篇 |
2005年 | 41748篇 |
2004年 | 39021篇 |
2003年 | 37738篇 |
2002年 | 36859篇 |
2001年 | 59619篇 |
2000年 | 61047篇 |
1999年 | 52299篇 |
1998年 | 14693篇 |
1997年 | 13235篇 |
1996年 | 13206篇 |
1995年 | 13158篇 |
1994年 | 12457篇 |
1993年 | 11273篇 |
1992年 | 41478篇 |
1991年 | 40792篇 |
1990年 | 40287篇 |
1989年 | 39048篇 |
1988年 | 36410篇 |
1987年 | 35589篇 |
1986年 | 33920篇 |
1985年 | 32308篇 |
1984年 | 24003篇 |
1983年 | 20857篇 |
1982年 | 12357篇 |
1981年 | 10918篇 |
1979年 | 22656篇 |
1978年 | 15851篇 |
1977年 | 13693篇 |
1976年 | 12944篇 |
1975年 | 14173篇 |
1974年 | 16685篇 |
1973年 | 16059篇 |
1972年 | 15313篇 |
1971年 | 14234篇 |
1970年 | 13207篇 |
1969年 | 12732篇 |
1968年 | 11976篇 |
排序方式: 共有10000条查询结果,搜索用时 33 毫秒
1.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
2.
3.
Jos B. Poell Leon J. Wils Arjen Brink Ralf Dietrich Christine Krieg Eunike Velleuer Ilkay Evren Elisabeth R. Brouns Jan G. de Visscher Elisabeth Bloemena Bauke Ylstra Ruud H. Brakenhoff 《International journal of cancer. Journal international du cancer》2023,152(2):227-238
Oral squamous cell carcinomas (OSCCs) develop in genetically altered epithelium in the mucosal lining, also coined as fields, which are mostly not visible but occasionally present as white oral leukoplakia (OL) lesions. We developed a noninvasive genetic assay using next-generation sequencing (NGS) on brushed cells to detect the presence of genetically altered fields, including those that are not macroscopically visible. The assay demonstrated high accuracy in OL patients when brush samples were compared with biopsies as gold standard. In a cohort of Fanconi anemia patients, detection of mutations in prospectively collected oral brushes predicted oral cancer also when visible abnormalities were absent. We further provide insight in the molecular landscape of OL with frequent changes of TP53, FAT1 and NOTCH1. NGS analysis of noninvasively collected samples offers a highly accurate method to detect genetically altered fields in the oral cavity, and predicts development of OSCC in high-risk individuals. Noninvasive genetic screening can be employed to screen high-risk populations for cancer and precancer, map the extension of OL lesions beyond what is visible, map the oral cavity for precancerous changes even when visible abnormalities are absent, test accuracy of promising imaging modalities, monitor interventions and determine genetic progression as well as the natural history of the disease in the human patient. 相似文献
4.
Jones type fifth metatarsal fractures pose a challenge to the foot and ankle surgeon, given documented high nonunion rates as well as high complication rates including hardware prominence, nerve injury, and screw breakage for existing treatment modalities including screw and plantar plate fixation. We call for the design of innovative Jones-fracture specific implants which contour to the natural curve of the fifth metatarsal. Future research should aim to expand upon existing literature for Jones fracture fixation and evaluate efficacy of novel implants which are designed to address unacceptably high complication rates for existing treatment modalities. 相似文献
5.
6.
7.
8.
9.
Dong-Xin Hu Qi-Feng Sun Lin Xu Hong-Da Lu Fan Zhang Zhen-Miao Li Ming-Yan Zhang 《World journal of gastroenterology : WJG》2022,28(4):464-478
BACKGROUND Esophageal squamous cell carcinoma(ESCC)is one of the most prevalent malignancies that seriously threaten people’s health worldwide.DEAD-box helicase 51(DDX51)is a member of the DEAD-box(DDX)RNA helicase family,and drives or inhibits tumor progression in multiple cancer types.AIM To determine whether DDX51 affects the biological behavior of ESCC.METHODS The expression of DDX51 in ESCC tumor tissues and adjacent normal tissues was detected by Immunohistochemistry(IHC)analyses and quantitative PCR(qPCR).We knocked down DDX51 in ESCC cell lines by using a small interfering RNA(siRNA)transfection.The proliferation,apoptosis,and mobility of DDX51 siRNAtransfected cells were detected.The effect of DDX51 on the phosphoinositide 3-kinase(PI3K)/AKT pathway was investigated by western blot analysis.A mouse xenograft model was established to investigate the effects of DDX51 knockdown on ESCC tumor growth.RESULTS DDX51 exhibited high expression in ESCC tissues compared with normal tissues and represented a poor prognosis in patients with ESCC.Knockdown of DDX51 induced inhibition of ESCC cell proliferation and promoted apoptosis.Moreover,DDX51 siRNA-expressing cells also exhibited lower migration and invasion rates.Investigations into the underlying mechanisms suggested that DDX51 knock down induced inactivation of the PI3K/AKT pathway,including decreased phosphorylation levels of phosphate and tensin homolog,PI3K,AKT,and mammalian target of rapamycin.Rescue experiments demonstrated that the AKT activator insulin-like growth factor 1 could reverse the inhibitory effects of DDX51 on ESCC malignant development.Finally,we injected DDX51 siRNA-transfected TE-1 cells into an animal model,which resulted in slower tumor growth.CONCLUSION Our study suggests for the first time that DDX51 promotes cancer cell proliferation by regulating the PI3K/AKT pathway;thus,DDX51 might be a therapeutic target for ESCC. 相似文献
10.
韦氏三联九针是“燕京韦氏眼科学术流派”工作室团队治疗多种眼病,尤其是视神经视网膜退行性疾病的重要针灸处方,临床实践显示疗效较好。笔者对韦氏三联九针法的起源、选穴配穴思路,三联不同部位的针刺手法操作要领进行了解读,并对近年来的研究进展进行了详细阐述。提出在遵循针灸理论基础上,传承并发展的三联九针法,可较大程度提高针灸治疗眼病的疗效。 相似文献